© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 2, 102-107,
January 16, 2002
© 2002 Oxford University Press
ARTICLE |
Effects of Age and Human Papilloma Viral Load on Colposcopy Triage: Data From the Randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
For the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group
Affiliations of authors: M. E. Sherman, M. Schiffman, Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; J. T. Cox, University of California Student Health Center, Santa Barbara.
Correspondence to: Mark E. Sherman, M.D., National Institutes of Health, 6120 Executive Blvd., Rm. 7080, Bethesda, MD 20892–7374 (e-mail: shermanm{at}mail.nih.gov).
Background: Testing for oncogenic human papillomavirus (HPV) DNA at a 1.0-pg/mL threshold represents a promising approach for colposcopy triage of atypical squamous cells of undetermined significance (ASCUS), but not for low-grade squamous intraepithelial lesions (LSIL). Considering age or viral load could improve colposcopy triage. Methods: We determined the sensitivity for detecting Cervical Intraepithelial Neoplasia 3 (CIN3) and cancer and the percentage of referrals for colposcopy using HPV testing and repeat thin-layer cytopathology in 2198 women with ASCUS and in 848 women with LSIL enrolled in ALTS from November 1996 through December 1998. We analyzed results by age and at two thresholds for HPV load and repeat cytopathology. Results: For ASCUS, the overall sensitivity of HPV testing at 1.0 pg/mL was 96.1% (95% confidence interval [CI] = 92.8 to 99.5%) and varied minimally with age (range, 93.9% to 97.8%). HPV testing at this threshold would refer 31.2% (95% CI = 28.0% to 34.3%) of women aged 29 years or older as compared with more than 65% of younger women. Among women aged 29 years or older with ASCUS, referral for repeat cytopathology of ASCUS had a sensitivity of 90.9% (95% CI = 81.1% to 100.0%) and would refer 50.1% (95% CI = 46.7 to 53.5%). Among all ASCUS, HPV testing using a 10.0-pg/mL threshold decreased sensitivity to 91.5% and referrals to 41.7%. More than 63% of LSIL would have been referred using any strategy achieving 90% sensitivity. Conclusion: For women with ASCUS, HPV testing was highly sensitive for detecting CIN3 and cancer with dramatically fewer referrals of older women. Neither a single HPV test nor repeat cytopathology provides useful triage for women with LSIL.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. E. Gravitt, L. J. van Doorn, W. Quint, M. Schiffman, A. Hildesheim, A. G. Glass, B. B. Rush, J. Hellman, M. E. Sherman, R. D. Burk, et al. Human Papillomavirus (HPV) Genotyping Using Paired Exfoliated Cervicovaginal Cells and Paraffin-Embedded Tissues To Highlight Difficulties in Attributing HPV Types to Specific Lesions J. Clin. Microbiol., October 1, 2007; 45(10): 3245 - 3250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Kovacic, P. E. Castle, R. Herrero, M. Schiffman, M. E. Sherman, S. Wacholder, A. C. Rodriguez, M. L. Hutchinson, M. C. Bratti, A. Hildesheim, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res., October 15, 2006; 66(20): 10112 - 10119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J P A Baak, A-J Kruse, S J Robboy, E A M Janssen, B van Diermen, and I Skaland Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers J. Clin. Pathol., October 1, 2006; 59(10): 1017 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Lillo and C. Uberti-Foppa Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women J. Antimicrob. Chemother., May 1, 2006; 57(5): 810 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Wright, J. S. Rader, R. Davila, M. A. Powell, D. G. Mutch, F. Gao, and R. K. Gibb Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet. Gynecol., April 1, 2006; 107(4): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Sawaya A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance JAMA, November 2, 2005; 294(17): 2210 - 2218. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fontaine, P. Gravitt, L.-M. Duh, J. Lefevre, K. Pourreaux, C. Hankins, F. Coutlee, and The Canadian Women's HIV Study Group High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2200 - 2207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. Chin-Hong, E. Vittinghoff, R. D. Cranston, L. Browne, S. Buchbinder, G. Colfax, M. Da Costa, T. Darragh, D. J. Benet, F. Judson, et al. Age-Related Prevalence of Anal Cancer Precursors in Homosexual Men: The EXPLORE Study J Natl Cancer Inst, June 15, 2005; 97(12): 896 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Boardman, C. Stanko, S. Weitzen, and C. J. Sung Atypical Squamous Cells of Undetermined Significance: Human Papillomavirus Testing in Adolescents Obstet. Gynecol., April 1, 2005; 105(4): 741 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Solomon and M. Schiffman RESPONSE: Re: Have We Resolved How To Triage Equivocal Cervical Cytology? J Natl Cancer Inst, September 15, 2004; 96(18): 1402 - 1402. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ng, R. Wilkins, M. F. K. Fung, and J.-M. Berthelot Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996 Can. Med. Assoc. J., May 11, 2004; 170(10): 1545 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Reesink-Peters, G. B. A. Wisman, C. Jeronimo, C. Y. Tokumaru, Y. Cohen, S. M. Dong, H. G. Klip, H. J. Buikema, A. J.H. Suurmeijer, H. Hollema, et al. Detecting Cervical Cancer by Quantitative Promoter Hypermethylation Assay on Cervical Scrapings: A Feasibility Study Mol. Cancer Res., May 1, 2004; 2(5): 289 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arbyn, F. Buntinx, M. V. Ranst, E. Paraskevaidis, P. Martin-Hirsch, and J. Dillner Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia J Natl Cancer Inst, February 18, 2004; 96(4): 280 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Wright Jr, M. Schiffman, D. Solomon, J. T. Cox, F. Garcia, S. Goldie, K. Hatch, K. L. Noller, N. Roach, C. Runowicz, et al. Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstet. Gynecol., February 1, 2004; 103(2): 304 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Goodman and D. C. Wilbur Case 32-2003 - A 37-Year-Old Woman with Atypical Squamous Cells on a Papanicolaou Smear N. Engl. J. Med., October 16, 2003; 349(16): 1555 - 1564. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sherman, S. S. Wang, C. M. Wheeler, L. Rich, P. E. Gravitt, R. Tarone, and M. Schiffman Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1038 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Gravitt, R. D. Burk, A. Lorincz, R. Herrero, A. Hildesheim, M. E. Sherman, M. C. Bratti, A. C. Rodriguez, K. J. Helzlsouer, and M. Schiffman A Comparison between Real-Time Polymerase Chain Reaction and Hybrid Capture 2 for Human Papillomavirus DNA Quantitation Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 477 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. X. Bosch and S. de Sanjose Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 3 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wang and A. Hildesheim Chapter 5: Viral and Host Factors in Human Papillomavirus Persistence and Progression J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 35 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iftner and L. L. Villa Chapter 12: Human Papillomavirus Technologies J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 80 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Solomon Chapter 14: Role of Triage Testing in Cervical Cancer Screening J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 97 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wacholder Chapter 18: Statistical Issues in the Design and Analysis of Studies of Human Papillomavirus and Cervical Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Sellors, T. L. Karwalajtys, J. Kaczorowski, J. B. Mahony, A. Lytwyn, S. Chong, J. Sparrow, and A. Lorincz Incidence, clearance and predictors of human papillomavirus infection in women Can. Med. Assoc. J., February 18, 2003; 168(4): 421 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sherman, A. T. Lorincz, D. R. Scott, S. Wacholder, P. E. Castle, A. G. Glass, I. Mielzynska-Lohnas, B. B. Rush, and M. Schiffman Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis J Natl Cancer Inst, January 1, 2003; 95(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Reesink-Peters, M N Helder, G B A Wisman, A J Knol, S Koopmans, H M Boezen, E Schuuring, H Hollema, E G E de Vries, S de Jong, et al. Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia J. Clin. Pathol., January 1, 2003; 56(1): 31 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Howard, J. Sellors, and J. Kaczorowski Optimizing the Hybrid Capture II Human Papillomavirus Test to Detect Cervical Intraepithelial Neoplasia Obstet. Gynecol., November 1, 2002; 100(5): 972 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, S. Wacholder, A. T. Lorincz, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, and M. Schiffman A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women J Natl Cancer Inst, September 18, 2002; 94(18): 1406 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Wright Jr, J. T. Cox, L. S. Massad, L. B. Twiggs, E. J. Wilkinson, and for the 2001 ASCCP-Sponsored Consensus Conference 2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities JAMA, April 24, 2002; 287(16): 2120 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Stoler New Bethesda Terminology and Evidence-Based Management Guidelines for Cervical Cytology Findings JAMA, April 24, 2002; 287(16): 2140 - 2141. [Full Text] [PDF]
|
|